Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 26% ± 8% | |
glutamatergic neuron | 7 studies | 37% ± 22% | |
GABAergic neuron | 5 studies | 38% ± 18% | |
astrocyte | 5 studies | 27% ± 9% | |
oligodendrocyte precursor cell | 5 studies | 29% ± 10% | |
interneuron | 4 studies | 37% ± 20% | |
neuron | 3 studies | 27% ± 8% | |
epithelial cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 30% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3172.07 | 2642 / 2642 | 100% | 108.58 | 705 / 705 |
ovary | 100% | 1528.42 | 180 / 180 | 100% | 22.77 | 430 / 430 |
prostate | 100% | 1216.86 | 245 / 245 | 100% | 23.09 | 502 / 502 |
thymus | 100% | 1335.85 | 652 / 653 | 100% | 25.26 | 605 / 605 |
kidney | 100% | 1052.96 | 89 / 89 | 100% | 15.92 | 898 / 901 |
skin | 100% | 1381.91 | 1800 / 1809 | 100% | 21.94 | 472 / 472 |
breast | 100% | 1096.54 | 457 / 459 | 100% | 22.93 | 1117 / 1118 |
bladder | 100% | 933.00 | 21 / 21 | 99% | 19.10 | 501 / 504 |
intestine | 99% | 1079.84 | 961 / 966 | 100% | 19.27 | 526 / 527 |
esophagus | 99% | 910.23 | 1433 / 1445 | 100% | 33.03 | 183 / 183 |
uterus | 99% | 1733.21 | 169 / 170 | 100% | 18.06 | 457 / 459 |
adrenal gland | 100% | 1503.68 | 257 / 258 | 99% | 19.69 | 228 / 230 |
stomach | 98% | 822.61 | 352 / 359 | 100% | 17.72 | 286 / 286 |
liver | 98% | 672.71 | 222 / 226 | 99% | 11.63 | 401 / 406 |
pancreas | 95% | 615.87 | 312 / 328 | 99% | 11.52 | 176 / 178 |
lung | 86% | 637.94 | 499 / 578 | 100% | 17.79 | 1154 / 1155 |
eye | 0% | 0 | 0 / 0 | 100% | 27.88 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.23 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 18.83 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.84 | 1 / 1 |
spleen | 100% | 899.96 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 998.72 | 1197 / 1204 | 0% | 0 | 0 / 0 |
muscle | 97% | 892.23 | 782 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 709.11 | 1291 / 1335 | 0% | 0 | 0 / 0 |
heart | 84% | 526.91 | 719 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 42% | 326.13 | 392 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0031179 | Biological process | peptide modification |
GO_0009789 | Biological process | positive regulation of abscisic acid-activated signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0005525 | Molecular function | GTP binding |
GO_0070273 | Molecular function | phosphatidylinositol-4-phosphate binding |
GO_0005515 | Molecular function | protein binding |
GO_0010314 | Molecular function | phosphatidylinositol-5-phosphate binding |
GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | LANCL2 |
Protein name | LanC like glutathione S-transferase 2 LanC-like protein 2 (Testis-specific adriamycin sensitivity protein) |
Synonyms | TASP GPR69B |
Description | FUNCTION: Necessary for abscisic acid (ABA) binding on the cell membrane and activation of the ABA signaling pathway in granulocytes. . |
Accessions | ENST00000254770.3 ENST00000452107.6 H7BZ40 Q9NS86 |